APO RESEARCH · REPORT
Pharma and Health Care
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Product & engineering
Understand the product.
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
Selected research
Market Structure
Global Pharma and Health Care Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
Read the full market overview
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
Report Includes
This report provides an overview of the global Pharma and Health Care market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharma and Health Care and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharma and Health Care revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharma and Health Care market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharma and Health Care Segment by Company
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Pharma and Health Care Segment by Format
Bottle
Blister
Others
Pharma and Health Care Segment by Prescription
OTC Drugs
Prescription Drugs
Pharma and Health Care Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharma and Health Care in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma and Health Care industry.
Chapter 3: Detailed analysis of Pharma and Health Care companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma and Health Carerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bottle
- Blister
- Others
Applications
- OTC Drugs
- Prescription Drugs
Companies covered
- Johnson & Johnson
- Novartis
- Roche
- AbbVie
- Merck & Co.
- Bristol Myers Squibb
- GlaxoSmithKline
- Pfizer
- Sanofi
- Takeda
- AstraZeneca
- Bayer
- Eli Lilly & Co.
- Gilead Sciences
- Amgen
- Novo Nordisk
- Teva
- Boehringer Ingelheim
- Biogen
- Astellas
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharma and Health Care Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Bottle
- 1.2.3 Blister
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharma and Health Care Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 OTC Drugs
- 1.3.3 Prescription Drugs
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharma and Health Care Growth Trends by Region
- 1.5.1 Global Pharma and Health Care Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharma and Health Care Market Size by Region (2021-2026)
- 1.5.3 Pharma and Health Care Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharma and Health Care Market Dynamics
- 2.1 Pharma and Health Care Industry Trends
- 2.2 Pharma and Health Care Industry Drivers
- 2.3 Pharma and Health Care Industry Opportunities and Challenges
- 2.4 Pharma and Health Care Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharma and Health Care Revenue by Company (2021-2026)
- 3.2 Global Pharma and Health Care Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharma and Health Care Key Company Head office and Area Served
- 3.4 Global Pharma and Health Care Company, Product Type & Application
- 3.5 Global Pharma and Health Care Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharma and Health Care Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharma and Health Care Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharma and Health Care Tier 1, Tier 2, and Tier 3
4 Pharma and Health Care Market by Type
- 4.1 Global Pharma and Health Care Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharma and Health Care Market Size by Type (2021-2032)
- 4.3 Global Pharma and Health Care Market Size Share by Type (2021-2032)
5 Pharma and Health Care Market by Application
- 5.1 Global Pharma and Health Care Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharma and Health Care Market Size by Application (2021-2032)
- 5.3 Global Pharma and Health Care Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Johnson & Johnson
- 6.1.1 Johnson & Johnson Company Information
- 6.1.2 Johnson & Johnson Business Overview
- 6.1.3 Johnson & Johnson Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Johnson & Johnson Pharma and Health Care Product Portfolio
- 6.1.5 Johnson & Johnson Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Novartis Pharma and Health Care Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Roche
- 6.3.1 Roche Company Information
- 6.3.2 Roche Business Overview
- 6.3.3 Roche Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Roche Pharma and Health Care Product Portfolio
- 6.3.5 Roche Recent Developments
- 6.4 AbbVie
- 6.4.1 AbbVie Company Information
- 6.4.2 AbbVie Business Overview
- 6.4.3 AbbVie Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 AbbVie Pharma and Health Care Product Portfolio
- 6.4.5 AbbVie Recent Developments
- 6.5 Merck & Co.
- 6.5.1 Merck & Co. Company Information
- 6.5.2 Merck & Co. Business Overview
- 6.5.3 Merck & Co. Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Merck & Co. Pharma and Health Care Product Portfolio
- 6.5.5 Merck & Co. Recent Developments
- 6.6 Bristol Myers Squibb
- 6.6.1 Bristol Myers Squibb Company Information
- 6.6.2 Bristol Myers Squibb Business Overview
- 6.6.3 Bristol Myers Squibb Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Bristol Myers Squibb Pharma and Health Care Product Portfolio
- 6.6.5 Bristol Myers Squibb Recent Developments
- 6.7 GlaxoSmithKline
- 6.7.1 GlaxoSmithKline Company Information
- 6.7.2 GlaxoSmithKline Business Overview
- 6.7.3 GlaxoSmithKline Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 GlaxoSmithKline Pharma and Health Care Product Portfolio
- 6.7.5 GlaxoSmithKline Recent Developments
- 6.8 Pfizer
- 6.8.1 Pfizer Company Information
- 6.8.2 Pfizer Business Overview
- 6.8.3 Pfizer Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Pfizer Pharma and Health Care Product Portfolio
- 6.8.5 Pfizer Recent Developments
- 6.9 Sanofi
- 6.9.1 Sanofi Company Information
- 6.9.2 Sanofi Business Overview
- 6.9.3 Sanofi Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Sanofi Pharma and Health Care Product Portfolio
- 6.9.5 Sanofi Recent Developments
- 6.10 Takeda
- 6.10.1 Takeda Company Information
- 6.10.2 Takeda Business Overview
- 6.10.3 Takeda Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Takeda Pharma and Health Care Product Portfolio
- 6.10.5 Takeda Recent Developments
- 6.11 AstraZeneca
- 6.11.1 AstraZeneca Company Information
- 6.11.2 AstraZeneca Business Overview
- 6.11.3 AstraZeneca Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 AstraZeneca Pharma and Health Care Product Portfolio
- 6.11.5 AstraZeneca Recent Developments
- 6.12 Bayer
- 6.12.1 Bayer Company Information
- 6.12.2 Bayer Business Overview
- 6.12.3 Bayer Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Bayer Pharma and Health Care Product Portfolio
- 6.12.5 Bayer Recent Developments
- 6.13 Eli Lilly & Co.
- 6.13.1 Eli Lilly & Co. Company Information
- 6.13.2 Eli Lilly & Co. Business Overview
- 6.13.3 Eli Lilly & Co. Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Eli Lilly & Co. Pharma and Health Care Product Portfolio
- 6.13.5 Eli Lilly & Co. Recent Developments
- 6.14 Gilead Sciences
- 6.14.1 Gilead Sciences Company Information
- 6.14.2 Gilead Sciences Business Overview
- 6.14.3 Gilead Sciences Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Gilead Sciences Pharma and Health Care Product Portfolio
- 6.14.5 Gilead Sciences Recent Developments
- 6.15 Amgen
- 6.15.1 Amgen Company Information
- 6.15.2 Amgen Business Overview
- 6.15.3 Amgen Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Amgen Pharma and Health Care Product Portfolio
- 6.15.5 Amgen Recent Developments
- 6.16 Novo Nordisk
- 6.16.1 Novo Nordisk Company Information
- 6.16.2 Novo Nordisk Business Overview
- 6.16.3 Novo Nordisk Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Novo Nordisk Pharma and Health Care Product Portfolio
- 6.16.5 Novo Nordisk Recent Developments
- 6.17 Teva
- 6.17.1 Teva Company Information
- 6.17.2 Teva Business Overview
- 6.17.3 Teva Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Teva Pharma and Health Care Product Portfolio
- 6.17.5 Teva Recent Developments
- 6.18 Boehringer Ingelheim
- 6.18.1 Boehringer Ingelheim Company Information
- 6.18.2 Boehringer Ingelheim Business Overview
- 6.18.3 Boehringer Ingelheim Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Boehringer Ingelheim Pharma and Health Care Product Portfolio
- 6.18.5 Boehringer Ingelheim Recent Developments
- 6.19 Biogen
- 6.19.1 Biogen Company Information
- 6.19.2 Biogen Business Overview
- 6.19.3 Biogen Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Biogen Pharma and Health Care Product Portfolio
- 6.19.5 Biogen Recent Developments
- 6.20 Astellas
- 6.20.1 Astellas Company Information
- 6.20.2 Astellas Business Overview
- 6.20.3 Astellas Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Astellas Pharma and Health Care Product Portfolio
- 6.20.5 Astellas Recent Developments
7 North America
- 7.1 North America Pharma and Health Care Market Size (2021-2032)
- 7.2 North America Pharma and Health Care Market Size by Type
- 7.2.1 North America Pharma and Health Care Market Size by Type (2021-2026)
- 7.2.2 North America Pharma and Health Care Market Size by Type (2027-2032)
- 7.2.3 North America Pharma and Health Care Market Share by Type (2021-2032)
- 7.3 North America Pharma and Health Care Market Size by Application
- 7.3.1 North America Pharma and Health Care Market Size by Application (2021-2026)
- 7.3.2 North America Pharma and Health Care Market Size by Application (2027-2032)
- 7.3.3 North America Pharma and Health Care Market Share by Application (2021-2032)
- 7.4 North America Pharma and Health Care Market Size by Country
- 7.4.1 North America Pharma and Health Care Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharma and Health Care Market Size by Country (2021-2026)
- 7.4.3 North America Pharma and Health Care Market Size by Country (2027-2032)
- 7.4.4 North America Pharma and Health Care Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharma and Health Care Market Size (2021-2032)
- 8.2 Europe Pharma and Health Care Market Size by Type
- 8.2.1 Europe Pharma and Health Care Market Size by Type (2021-2026)
- 8.2.2 Europe Pharma and Health Care Market Size by Type (2027-2032)
- 8.2.3 Europe Pharma and Health Care Market Share by Type (2021-2032)
- 8.3 Europe Pharma and Health Care Market Size by Application
- 8.3.1 Europe Pharma and Health Care Market Size by Application (2021-2026)
- 8.3.2 Europe Pharma and Health Care Market Size by Application (2027-2032)
- 8.3.3 Europe Pharma and Health Care Market Share by Application (2021-2032)
- 8.4 Europe Pharma and Health Care Market Size by Country
- 8.4.1 Europe Pharma and Health Care Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharma and Health Care Market Size by Country (2021-2026)
- 8.4.3 Europe Pharma and Health Care Market Size by Country (2027-2032)
- 8.4.4 Europe Pharma and Health Care Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharma and Health Care Market Size (2021-2032)
- 9.2 China Pharma and Health Care Market Size by Type
- 9.2.1 China Pharma and Health Care Market Size by Type (2021-2026)
- 9.2.2 China Pharma and Health Care Market Size by Type (2027-2032)
- 9.2.3 China Pharma and Health Care Market Share by Type (2021-2032)
- 9.3 China Pharma and Health Care Market Size by Application
- 9.3.1 China Pharma and Health Care Market Size by Application (2021-2026)
- 9.3.2 China Pharma and Health Care Market Size by Application (2027-2032)
- 9.3.3 China Pharma and Health Care Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharma and Health Care Market Size (2021-2032)
- 10.2 Asia Pharma and Health Care Market Size by Type
- 10.2.1 Asia Pharma and Health Care Market Size by Type (2021-2026)
- 10.2.2 Asia Pharma and Health Care Market Size by Type (2027-2032)
- 10.2.3 Asia Pharma and Health Care Market Share by Type (2021-2032)
- 10.3 Asia Pharma and Health Care Market Size by Application
- 10.3.1 Asia Pharma and Health Care Market Size by Application (2021-2026)
- 10.3.2 Asia Pharma and Health Care Market Size by Application (2027-2032)
- 10.3.3 Asia Pharma and Health Care Market Share by Application (2021-2032)
- 10.4 Asia Pharma and Health Care Market Size by Country
- 10.4.1 Asia Pharma and Health Care Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharma and Health Care Market Size by Country (2021-2026)
- 10.4.3 Asia Pharma and Health Care Market Size by Country (2027-2032)
- 10.4.4 Asia Pharma and Health Care Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharma and Health Care Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharma and Health Care Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharma and Health Care Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharma and Health Care Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharma and Health Care Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharma and Health Care Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharma and Health Care Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharma and Health Care Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharma and Health Care Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharma and Health Care Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharma and Health Care Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharma and Health Care Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharma and Health Care Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharma and Health Care Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst